SHA-256: ba8ff81d524c23c4651fe153a0e2d09d916b90b20164f7d344ec9503db37ce38
This paper asks a narrower and more disciplined question than "are psychedelics permissible in Islam" — it asks whether classical psychedelics (mainly psilocybin and 5-MeO-DMT) actually meet the classical juristic criteria for muskir, the ḥadd-bearing category that governs khamr, and works through that classification question using the tradition's own tools rather than assuming an answer.
The argument sits inside established methodology rather than outside it — taḥqīq al-manāt, the process of testing whether a new case actually falls under an existing ruling's cause ('illa). It engages the khamr prohibition directly (conceding the drop-rule and ḥadd-attaches-to-the-act principle in full), works through al-Qarāfī's four-part taxonomy of intoxicating substances, and tests Ibn Taymiyya's own criteria — including his banj ruling — on their own terms rather than around them.
Medical use of classical psychedelics is defensible on established Islamic legal principle for conditions like treatment-resistant depression and PTSD, under supervised, purpose-limited, clinically-administered conditions.
Spiritual use is also supported, though on thinner ground. Neither is unrestricted — both stay bounded by supervision and defined purpose, with recreational or unsupervised use excluded throughout.
The paper treats this as a working draft: nine objections are answered directly, several honestly left unresolved rather than papered over, and the whole argument is offered for scrutiny rather than presented as settled.